FLUZONE TRIVALENT NORTHERN HEMISPHERE
NDC 83703-087, INFLUENZA A VIRUS A/Victoria/4897/2022 IVR-238 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/Croatia/10136/RV/2023 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED), and INFLUENZA B VIRUS B/MICHIGAN/01/2021 ANTIGEN (FORMALDEHYDE INACTIVATED), injection, suspension, from Bamboo US BidCo LLC.
- Product NDC
- 83703-087
- Status
- Listed
- Labeler
- Bamboo US BidCo LLC
- Dosage form
- INJECTION, SUSPENSION
- Route
- INTRAMUSCULAR
- Product type
- VACCINE
- Marketing category
- BLA
- Application
- BLA103914
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/83703-087 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- INFLUENZA A VIRUS A/VICTORIA/4897/2022 IVR-238 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED)15 ug/.5mL
- INFLUENZA A VIRUS A/CROATIA/10136RV/2023 X-425A (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED)15 ug/.5mL
- INFLUENZA B VIRUS B/MICHIGAN/01/2021 ANTIGEN (FORMALDEHYDE INACTIVATED)15 ug/.5mL
| Package NDC | NDC-11 | Package |
|---|---|---|
| 83703-087-50 | 83703008750 | 10 SYRINGE, GLASS in 1 PACKAGE (83703-087-50) / .5 mL in 1 SYRINGE, GLASS (83703-087-88) |
Linked data
RxNorm, label and prices
RxNorm concepts
RxNorm links no concept to this product's packages.
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 83703-087 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/83703-087 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 83703-087. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.